Concepedia

Author

Arié Figer

Tel Aviv Sourasky Medical Center

Also Known As

A Figer, A. Figer, Arie Figer, Arié Figer

132

Publications

19.7K

Citations

41

H-Index

78

Concepts

All Affiliations

Tel Aviv Sourasky Medical CenterTel Aviv UniversityRabin Medical CenterSheba Medical CenterMeir Medical Center
AF

About

Arié Figer is an author at Tel Aviv Sourasky Medical Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

40

2.4K

2

Health Sciences

11

11

594

3

Public Health

5

5

269

4

Cell Biology

2

2

137

5

Social Sciences

1

1

11

Arié Figer

×

83

Publications

19.5K

Citations

41

H-Index

YearCitations

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, David Goldstein, John Hamm,

Journal of Clinical Oncology

2007

3.8K

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Aimery de Gramont, Arié Figer, Michel Seymour,

Journal of Clinical Oncology

2000

3.8K

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Leonard B. Saltz, Stephen Clarke, Eduardo Díaz‐Rubio,

Journal of Clinical Oncology

2008

3K

Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Ghassan K. Abou‐Alfa, Lawrence H. Schwartz, Sergio Ricci,

Journal of Clinical Oncology

2006

1.2K

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

Jim Cassidy, Stephen Clarke, Eduardo Díaz‐Rubio,

Journal of Clinical Oncology

2008

858

OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study

Christophe Tournigand, Andrés Cervantes, Arié Figer,

Journal of Clinical Oncology

2006

799

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Richard Herrmann, G. Bodoky, Thomas Ruhstaller,

Journal of Clinical Oncology

2007

590

XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer

Jim Cassidy, Josep Tabernero, Chris Twelves,

Journal of Clinical Oncology

2004

522

An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal Cancer

Hagit Tulchinsky, Einat Shmueli, Arié Figer,

Annals of Surgical Oncology

2008

303

Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients

Hans‐Joachim Schmoll, Thomas H. Cartwright, Josep Tabernero,

Journal of Clinical Oncology

2006

296

Page 1